From: The inhibitory effects of carvacrol, nystatin, and their combination on oral candidiasis isolates
MIC (µg/mL) Mean ± STD | MFC (µg/mL) Mean ± STD | MTT (%) Mean ± STD | ||
---|---|---|---|---|
Candida albicans | Carvacrol | 22.87 ± 7.5 | 44.38 ± 14.29 | 49.97 ± 8.82 |
Nystatin | 81.67 ± 40.81 | 160.78 ± 82.35 | 30.75 ± 10.5 | |
Nystatin + Carvacrol | 39.31 ± 21.17 | 80.56 ± 44.58 | 78.41 ± 11.34 | |
p-value | < 0.001 | < 0.001 | < 0.001 | |
Candida glabrata | Carvacrol | 27.30 ± 6.88 | 52.19 ± 13.77 | 50.2 ± 9.33 |
Nystatin | 80.24 ± 24.17 | 160 ± 49 | 31.2 ± 10.7 | |
Nystatin + Carvacrol | 40.91 ± 22.25 | 82 ± 44 | 76 ± 10 | |
p-value | Not significant | Not significant | Not significant | |
Candida krusei | Carvacrol | 28.71 ± 4.89 | 56.25 ± 8.79 | 43.93 ± 8.24 |
Nystatin | 75.83 ± 20.10 | 145 ± 43 | 35.3 ± 8.2 | |
Nystatin + Carvacrol | 49.76 ± 16.81 | 99 ± 22 | 77 ± 10 | |
p-value | Not significant | Not significant | Not significant | |
Candida tropicalis | Carvacrol | 25.47 ± 5.21 | 49.8 ± 10.77 | 53.51 ± 15.88 |
Nystatin | 74.78 ± 24.8 | 146 ± 45 | 29.6 ± 9.7 | |
Nystatin + Carvacrol | 31.56 ± 13.49 | 63 ± 28 | 81 ± 10 | |
p-value | Not significant | Not significant | Not significant | |
Candida (glabrata + krusei + tropicalis) | Carvacrol | 27.13 ± 6.36 | 52.25 ± 12.68 | 50.04 ± 10.76 |
Nystatin | 78.69 ± 23.49 | 155 ± 47 | 31.4 ± 10.2 | |
Nystatin + Carvacrol | 40.27 ± 20.63 | 80 ± 41 | 77 ± 10 | |
p-value | < 0.001 | < 0.001 | < 0.001 | |
All species | Carvacrol | 24.96 ± 7.25 | 48.23 ± 14.03 | 50.01 ± 9.77 |
Nystatin | 80.21 ± 33.33 | 158 ± 67 | 31.1 ± 10.3 | |
Nystatin + Carvacrol | 39.78 ± 20.81 | 81 ± 43 | 78 ± 11 | |
p-value | < 0.001 | < 0.001 | < 0.001 |